NVIDIA is at the forefront of powering a new era in molecular science where AI and GPU acceleration turn massive biological data into breakthroughs that unify AI and physics to model and design life.

Terray Therapeutics, an AI-native, chemistry-first, biotech today announced its AI and experimental platform, EMMI, and the introduction of advanced Select models that choose the most impactful ...

As part of the world’s largest gathering for pulmonary fibrosis (PF) and interstitial lung disease (ILD) research and education, Insilico will highlight significant ...

This article and associated images are based on a poster originally authored by Greta Klejborowska, Łukasz Szczupak, Jan Kulczycki, Łukasz Sztukiewicz, Piotr Setny, Michał Michalski, Karolina ...

Thousands of proteins are known to cause disease, but while the biological activity of these proteins is understood, the way to hit and modulate them with a drug is not. Nature still has ways to bind ...

To obtain a systematic view of Pharma.AI, the generative AI-driven solution for drug discovery and more cutting-edge research, please refer to the following answers provided by the Insilico AI team.

Five years after launching one of the most promising generative biology drug discovery companies, Generate Biomedicines, venture capital powerhouse Flagship Pioneering has brought a generative ...

After three years of internal development, Expedition is building a generative AI platform for covalent drug discovery, supported by a $50M initial commitment from Flagship Pioneering Multi-target ...